Descriptive Analysis Of Efficacy And Safety Of The Ipcsk9 After More One Year Of Its Use In A Third Level Hospital
ATHEROSCLEROSIS(2018)
Abstract
Aim: iPCSK9 has shown to reduce LDLc levels by more than 50% and other atherogenic lipids, as well as a modest increase of HDLc.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined